• Doina AZOICAI “Grigore T. Popa” University of Medicine and Pharmacy Iasi
Keywords: COVID-19, pandemy


Over time, humanity has gone through such moments that have resulted in suffering, loss of lives, economic crises, and social change. Epidemiological theories predict that at an interval of 100 years pandemic events may evolve as a consequence of the phenomena of adaptation of microorganisms and the crossing of barriers between species, some of which cause devastating diseases in the human population. By prospecting the history of these events, in the last hundred years there have been several crisis events with a tendency towards the evolution of new pandemics or epidemic phenomena with pandemic risk. The Spanish flu pandemic in 1918 was followed by the Asian flu pandemic (1957), the seventh cholera pandemic (1968-1975), the Hong Kong flu pandemic (1968), the HIV/AIDS pandemic (since 1981), a new type of influenza A (H1N1) pandemic (2009), but also some epidemic events that had all the chances to evolve towards pandemic manifestations such as: the epidemic of acute bovine spongiform encephalitis with a tendency to spread to humans (1996), localized avian influenza A (H5N1) epidemics (1997), Severe Acute Respiratory Syndrome - SARS (2002/2003), Middle East Respiratory Syndrome - MERS (2021), West African Ebola epidemic (2013/2014), Zika virus infection (2015). All these culminated in 2019 with the entry into circulation of a new coronavirus, SARS-CoV-2, different in varying proportions from SARS (genetic similarity of 80%) or MERS (genetic similarity of 50%) (1, 2). These global alerts have surprised the often-unprepared population and an unfortunate experience was quickly forgotten for various reasons but especially by the fact that the 21st century has installed itself in an effervescence of changes through an alert pace of technology, population movement and information explosion.

Author Biography

Doina AZOICAI, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

President of The Romanian Society of  Epidemiology


1. Saxena SK. Coronavirus disease 2019 (COVID-19). Epidemiology, pathogenesis, diagnosis and therapeutics. Springer, 2020.
2. World Economic Forum. A visual history of pandemics. Available online
3. WHO. Coronavirus disease 2019 (COVID-19) Situation Report-24, 13th February 2020.
4. van Doremalen N, Morris DH, Holbrook MG, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020; 382: 1564-1567.
5. Liu Y, Ning Z, Chen Y, et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature 2020; 582: 557-560.
6. Olsen SJ, Chang HL, Cheung TYY, et al. Transmission of the Severe Acute Respiratory Syndrome on Aircraft. Dec 18, 2003. N Engl J Med 2003; 349: 2416-2422.
7. Gandhi M, Yokoe DS, Havlir DV. Asymptomatic Transmission, the Achilles’ Heel of Current Strate-gies to Control Covid-19. N Engl J Med 2020; 382: 2158-2160.
8. Nishiura H, Kobayashi T, Miyama T, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Internat J Infect Dis 2020; 94: 154-155.
9. Baker RE, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic. Science 2020; 369, 6501: 315-319.
10. ECDC. Rapid risk assessment. Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – eighth update, 8 April 2020.
11. Liu M, He P, Liu H, et al. Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia. Chin J Tuberc Respir Dis 2020; 43: E016.
12. ECDC. Technical report. Strategies for the surveillance of COVID -19, 9 April 2020.
13. ECDC. Immune responses and immunity to SARS-CoV-2. 30 June 2020.
14. ECDC. Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – eleventh update: resur-gence of cases, 10 August 2020.
15. Cárdenas-González M, Álvarez-Buylla ER. The COVID-19 Pandemic and Paradigm Change. MEDICC Review 2020; 22: 14-18.
16. Paul E, Brown GW, Ridde V. COVID-19: time for paradigm shift in the nexus between local, national and global health. BMJ Global Health 2020; 5: e002622.